Expression of AMPA and NMDA Receptor Subunits in the Cervical Spinal Cord of Wobbler Mice

Overview

Journal BMC Neurosci

Publisher Biomed Central

Specialty Neurology

Date 2006 Oct 28

PMID 17067377

Citations 8

Authors

Paolo Bigini

Fabrizio Gardoni

Sara Barbera

Alfredo Cagnotto

Elena Fumagalli

Annalisa Longhi

Massimiliano M Corsi

Monica Di Luca

Tiziana Mennini

Affiliations

Soon will be listed here.

Abstract

Background: The localisation of AMPA and NMDA receptor subunits was studied in a model of degeneration of cervical spinal motoneurons, the wobbler mouse. Cervical regions from early or late symptomatic wobbler mice (4 or 12 weeks of age) were compared to lumbar tracts (unaffected) and to those of healthy mice.

Results: No differences were found in the distribution of AMPA and NMDA receptor subunits at both ages. Western blots analysis showed a trend of reduction in AMPA and NMDA receptor subunits, mainly GluR1 and NR2A, exclusively in the cervical region of late symptomatic mice in the triton-insoluble post-synaptic fraction but not whole homogenates. Colocalisation experiments evidenced the expression of GluR1 and NR2A receptors in activated astrocytes from the cervical spinal cord of wobbler mice, GluR2 did not colocalise with GFAP positive cells. No differences were found in the expression of AMPA and NMDA receptor subunits in the lumbar tract of wobbler mice, where neither motoneuron loss nor reactive gliosis occurs.

Conclusion: In late symptomatic wobbler mice altered levels of GluR1 and NR2A receptor subunits may be a consequence of motoneuron loss rather than an early feature of motoneuron vulnerability.

Citing Articles

The wobbler mouse, an ALS animal model.

Moser J, Bigini P, Schmitt-John T Mol Genet Genomics. 2013; 288(5-6):207-29.

PMID: 23539154 PMC: 3664746. DOI: 10.1007/s00438-013-0741-0.

Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implications.

Louboutin J, Strayer D ScientificWorldJournal. 2012; 2012:482575.

PMID: 22448134 PMC: 3289936. DOI: 10.1100/2012/482575.

Longitudinal tracking of human fetal cells labeled with super paramagnetic iron oxide nanoparticles in the brain of mice with motor neuron disease.

Bigini P, Diana V, Barbera S, Fumagalli E, Micotti E, Sitia L PLoS One. 2012; 7(2):e32326.

PMID: 22384217 PMC: 3288077. DOI: 10.1371/journal.pone.0032326.

Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage.

Louboutin J, Chekmasova A, Marusich E, Agrawal L, Strayer D FASEB J. 2010; 25(2):737-53.

PMID: 20940264 PMC: 3023386. DOI: 10.1096/fj.10-161851.

Gene transfer to the cerebellum.

Louboutin J, Reyes B, Van Bockstaele E, Strayer D Cerebellum. 2010; 9(4):587-97.

PMID: 20700772 DOI: 10.1007/s12311-010-0202-9.

References

Tomiyama M, Kannari K, Nunomura J, Oyama Y, Takebe K, Matsunaga M . Quantitative autoradiographic distribution of glutamate receptors in the cervical segment of the spinal cord of the wobbler mouse. Brain Res. 1994; 650(2):353-7. DOI: 10.1016/0006-8993(94)91805-8. View

Brooks B . El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases.... J Neurol Sci. 1994; 124 Suppl:96-107. DOI: 10.1016/0022-510x(94)90191-0. View

Cambier D, Parvy P, Murawsky M, Rieger F . Excess extracellular and low intracellular glutamate in poorly differentiating wobbler astrocytes and astrocyte recovery in glutamine-depleted culture medium. J Neurochem. 1995; 65(3):1199-204. DOI: 10.1046/j.1471-4159.1995.65031199.x. View

Cudkowicz M, McKenna-Yasek D, Sapp P, Chin W, Geller B, Hayden D . Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol. 1997; 41(2):210-21. DOI: 10.1002/ana.410410212. View

Rowland L . Diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1998; 160 Suppl 1:S6-24. DOI: 10.1016/s0022-510x(98)00193-2. View

Gonzalez Deniselle M, Gonzalez S, Lima A, Wilkin G, De Nicola A . The 21-aminosteroid U-74389F attenuates hyperexpression of GAP-43 and NADPH-diaphorase in the spinal cord of wobbler mouse, a model for amyotrophic lateral sclerosis. Neurochem Res. 1999; 24(1):1-8. DOI: 10.1023/a:1020918310281. View

Kuner R, Groom A, Muller G, Kornau H, Stefovska V, Bresink I . Mechanisms of disease: motoneuron disease aggravated by transgenic expression of a functionally modified AMPA receptor subunit. Ann N Y Acad Sci. 2005; 1053:269-86. DOI: 10.1196/annals.1344.024. View

Schmitt-John T, Drepper C, Mussmann A, Hahn P, Kuhlmann M, Thiel C . Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse. Nat Genet. 2005; 37(11):1213-5. DOI: 10.1038/ng1661. View

Tortarolo M, Grignaschi G, Calvaresi N, Zennaro E, Spaltro G, Colovic M . Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease. J Neurosci Res. 2005; 83(1):134-46. DOI: 10.1002/jnr.20715. View

10.

Fumagalli E, Bigini P, Barbera S, De Paola M, Mennini T . Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease. Exp Neurol. 2006; 198(1):114-28. DOI: 10.1016/j.expneurol.2005.11.010. View

11.

Finardi A, Gardoni F, Bassanini S, Lasio G, Cossu M, Tassi L . NMDA receptor composition differs among anatomically diverse malformations of cortical development. J Neuropathol Exp Neurol. 2006; 65(9):883-93. DOI: 10.1097/01.jnen.0000235117.67558.6d. View

12.

Gardoni F, Schrama L, Kamal A, Gispen W, Cattabeni F, Di Luca M . Hippocampal synaptic plasticity involves competition between Ca2+/calmodulin-dependent protein kinase II and postsynaptic density 95 for binding to the NR2A subunit of the NMDA receptor. J Neurosci. 2001; 21(5):1501-9. PMC: 6762931. View

13.

Takuma H, Kwak S, Yoshizawa T, Kanazawa I . Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis. Ann Neurol. 1999; 46(6):806-15. DOI: 10.1002/1531-8249(199912)46:6<806::aid-ana2>3.0.co;2-s. View

14.

Tsuzaka K, Ishiyama T, Pioro E, Mitsumoto H . Role of brain-derived neurotrophic factor in wobbler mouse motor neuron disease. Muscle Nerve. 2001; 24(4):474-80. DOI: 10.1002/mus.1029. View

15.

Bigini P, Bastone A, Mennini T . Glutamate transporters in the spinal cord of the wobbler mouse. Neuroreport. 2001; 12(9):1815-20. DOI: 10.1097/00001756-200107030-00011. View

16.

Canton T, Bohme G, Boireau A, Bordier F, Mignani S, Jimonet P . RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis. J Pharmacol Exp Ther. 2001; 299(1):314-22. View

17.

Kawahara Y, Kwak S, Sun H, Ito K, Hashida H, Aizawa H . Human spinal motoneurons express low relative abundance of GluR2 mRNA: an implication for excitotoxicity in ALS. J Neurochem. 2003; 85(3):680-9. DOI: 10.1046/j.1471-4159.2003.01703.x. View

18.

Kozachuk W, Mitsumoto H, Salanga V, Beck G, Wilber J . Thyrotropin-releasing hormone (TRH) in murine motor neuron disease (the wobbler mouse). J Neurol Sci. 1987; 78(3):253-60. DOI: 10.1016/0022-510x(87)90039-6. View

19.

Blondet B, Barlovatz-Meimon G, Festoff B, Soria C, Soria J, Rieger F . Plasminogen activators in the neuromuscular system of the wobbler mutant mouse. Brain Res. 1992; 580(1-2):303-10. DOI: 10.1016/0006-8993(92)90958-c. View

20.

Krieger C, Perry T, Hansen S, Mitsumoto H, Honore T . Excitatory amino acid receptor antagonist in murine motoneuron disease (the wobbler mouse). Can J Neurol Sci. 1992; 19(4):462-5. View